MedTrace Logo

The PROOF Study: The PICC Related Obstruction Of Flow Study

NCT01921114 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2019-05-17

Study results available
· View outcomes & findings →

Summary

The main purpose of this study is to confirm whether the AngioDynamics BioFlo™ Peripherally Inserted Central Catheter (PICC) is associated with less formation of blood clots compared to another commercially available PICC.

Conditions

  • Patients Indicated for a PICC for Any Medical Condition

Interventions

DEVICE

BioFlo™ Peripherally Inserted Central Catheter (PICC)

DEVICE

Bard® Dual-Lumen PowerPICC SOLO2®

Sponsors & Collaborators

  • Angiodynamics, Inc.

    lead INDUSTRY

Principal Investigators

  • David Hahn, MD · Endeavor Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-07-31
Completion
2014-08-31

Countries

  • United States
  • Canada
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01921114 on ClinicalTrials.gov